Stock overview
Nuvalent Inc.
Explore the company, reported ownership, price history, and available source evidence.
Historical Nuvalent Class A common stock, traded as NUVL. GSK acquired the company for $124.00 cash per share on July 15, 2026. Trading halted after the July 14 close and did not resume.
- Last close
- $123.96
- · NUVL
- Tracked holders
- 2 funds
- Latest available 13F per fund
NUVL · USD
Price
Close · Jul 14, 2026
- Range low
- $123.97
- Range high
- $123.97
- Observations
- 1
- Session date
- Jul 14, 2026
Jul 14, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
No holders match this filter.
Try another movement slice or return to the full holder table.
Show all holdersSEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market